Lester Lee

Array ( [id] => 2953328 [patent_doc_number] => 05242901 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-09-07 [patent_title] => 'Reduction of anthracycline induced cardiotoxicity' [patent_app_type] => 1 [patent_app_number] => 7/860581 [patent_app_country] => US [patent_app_date] => 1992-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6279 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/242/05242901.pdf [firstpage_image] =>[orig_patent_app_number] => 860581 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2904348 [patent_doc_number] => 05215896 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-06-01 [patent_title] => 'Leader sequences for the production of recombinant proteins' [patent_app_type] => 1 [patent_app_number] => 7/857684 [patent_app_country] => US [patent_app_date] => 1992-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 8985 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 207 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/215/05215896.pdf [firstpage_image] =>[orig_patent_app_number] => 857684 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2890225 [patent_doc_number] => 05240712 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-08-31 [patent_title] => 'Therapeutic agents' [patent_app_type] => 1 [patent_app_number] => 7/856870 [patent_app_country] => US [patent_app_date] => 1992-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3590 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/240/05240712.pdf [firstpage_image] =>[orig_patent_app_number] => 856870 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2905896 [patent_doc_number] => 05248764 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-09-28 [patent_title] => 'Chelate derivatives of atrial natriuretic factor (ANF)' [patent_app_type] => 1 [patent_app_number] => 7/842753 [patent_app_country] => US [patent_app_date] => 1992-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1991 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/248/05248764.pdf [firstpage_image] =>[orig_patent_app_number] => 842753 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3411562 [patent_doc_number] => 05411943 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-05-02 [patent_title] => 'Hepatoma treatment with somatostatin analogs' [patent_app_type] => 1 [patent_app_number] => 7/840881 [patent_app_country] => US [patent_app_date] => 1992-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 3645 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/411/05411943.pdf [firstpage_image] =>[orig_patent_app_number] => 840881 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3065118 [patent_doc_number] => 05352659 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-10-04 [patent_title] => 'Endothelin analogs and uses thereof' [patent_app_type] => 1 [patent_app_number] => 7/837780 [patent_app_country] => US [patent_app_date] => 1992-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11015 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/352/05352659.pdf [firstpage_image] =>[orig_patent_app_number] => 837780 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3456383 [patent_doc_number] => 05378807 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-01-03 [patent_title] => '.gamma.-poly(glutamic acid) esters' [patent_app_type] => 1 [patent_app_number] => 7/832255 [patent_app_country] => US [patent_app_date] => 1992-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 4455 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/378/05378807.pdf [firstpage_image] =>[orig_patent_app_number] => 832255 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2937368 [patent_doc_number] => 05190921 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-03-02 [patent_title] => 'Amino acids and peptides having a modified tyrosine residue, their preparation and their application as medicaments' [patent_app_type] => 1 [patent_app_number] => 7/825294 [patent_app_country] => US [patent_app_date] => 1992-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12526 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 483 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/190/05190921.pdf [firstpage_image] =>[orig_patent_app_number] => 825294 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3018023 [patent_doc_number] => 05302581 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-04-12 [patent_title] => 'Pulmonary surfactant protein fragments' [patent_app_type] => 1 [patent_app_number] => 7/826323 [patent_app_country] => US [patent_app_date] => 1992-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6187 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/302/05302581.pdf [firstpage_image] =>[orig_patent_app_number] => 826323 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2805433 [patent_doc_number] => 05147867 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-09-15 [patent_title] => 'Phosphorus containing enzyme inhibitors' [patent_app_type] => 1 [patent_app_number] => 7/824738 [patent_app_country] => US [patent_app_date] => 1992-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13404 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 460 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/147/05147867.pdf [firstpage_image] =>[orig_patent_app_number] => 824738 [rel_patent_id] =>[rel_patent_doc_number] =>)